CTNNB1 and osteoporosis: DKK1 is an endogenous inhibitor of the Wnt/beta-catenin signalling pathway and is implicated in bone development and in the pathological remodelling of bone in both OA and osteoporosis and mediating inflammation-induced bone loss by inhibiting osteoblast differentiation [30,31].